Keyphrases
Plasma Glucose
100%
Type 2 Diabetes Mellitus (T2DM)
96%
Ectopic Pregnancy
82%
2-h Plasma Glucose
79%
Hemoglobin A1c (HbA1c)
62%
High-dose Methotrexate (HD-MTX)
62%
Methotrexate Treatment
62%
Type 2 Diabetes Mellitus Risk
57%
Type 2 Diabetes Risk
53%
Future Risk
51%
Methotrexate
51%
High Risk
49%
San Antonio
46%
Oral Glucose Tolerance Test
46%
Diabetes Subgroups
41%
Safety Effectiveness
41%
Qatar
41%
Pharmacological Treatment
41%
Risk Score
41%
Metabolic Syndrome
41%
Glucose-lowering Drugs
41%
Cost-effectiveness
41%
Two-step Approach
41%
Glycated Hemoglobin
41%
β-cell Function
31%
Severe Insulin Resistance
31%
Non-diabetic
26%
Optimal Cutoff
26%
Surgical Intervention
24%
Lipid Profile
22%
Multivariate Logistic Models
22%
Insulin Deficiency
20%
Prediction Accuracy
20%
Insulin Sensitivity
20%
Area under the Receiver Operating Characteristic Curve
20%
Treatment Failure
20%
Nursing and Health Professions
Ectopic Pregnancy
82%
Methotrexate
82%
Single Drug Dose
62%
Non Insulin Dependent Diabetes Mellitus
41%
Hemoglobin A1c
41%
Glycosylated Hemoglobin
41%
Drug Therapy
41%
Cost Effectiveness Analysis
41%
Receiver Operating Characteristic
30%
Glucose Blood Level
23%
Medicine and Dentistry
Maturity Onset Diabetes of the Young
82%
Drug Therapy
41%
Metabolic Syndrome
41%
Methotrexate
41%
Ectopic Pregnancy
41%
Cost-Effectiveness Analysis
41%
Oral Glucose Tolerance Test
28%
Cell Function
24%
Beta Cell
24%
Insulin Resistance
24%
Hemoglobin A1c
24%
Single Drug Dose
20%
